Tuesday, April 16, 2019 7:23:52 PM
Looks like they are getting serious about generating investment to grow the business - Common shares outstanding has not changed which is a good thing, no dilution. Their revenue in one year from 2017 to 2018 has grown 10 fold which is another indicator of potential growth this year. Hold for the long run - what do you think comments
Financial Statement:
A. Fiscal year ending Dec. 31, 2018:
(i) Authorized – 800,000,000 common at no par value, 10,000,000 Series A
Preferred at no par value.
(ii) Total Issued & Outstanding 204,969,031 common, 274,550 Series A
Preferred.
Item 5. The Par or Stated Value of the Security
The company currently has authorized Eight Hundred Ten Million (810,000,000)
shares of stock at no par value which consists of Eight Hundred Million
(800,000,000) shares of common stock at no par value and Ten Million
(10,000,000) shares of preferred Series A stock at $1.00 par value.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM